Literature DB >> 32964971

LncRNA HMGA1P4 promotes cisplatin-resistance in gastric cancer.

X-L Qiao1, Z-L Zhong, Y Dong, F Gao.   

Abstract

OBJECTIVE: Long non-coding RNA (lncRNA) HMGA1P4 has been previously reported to be upregulated in gastric cancer (GC). This study aims to investigate the role of HMGA1P4 in cisplatin (DDP)-resistant GC. PATIENTS AND METHODS: HMGA1P4 levels in DDP-resistant GC tissues and cells were determined. Regulatory effects of HMGA1P4 on proliferative and apoptotic abilities in DDP-resistant GC cells and their parental cells were assessed. At last, expression levels of genes associated with multidrug-resistance (MDR) (MDR1, MRP1, mTOR and HIF-1α) and apoptosis (Bax, Bcl-2 and Caspase3) were determined in DDP-resistant GC cells.
RESULTS: Results revealed that HMGA1P4 was upregulated in DDP-resistant GC tissues and cells. Overexpression of HMGA1P4 stimulated proliferative rate and suppressed apoptosis in both DDP-resistant GC cells and their parental cells. Moreover, in DDP-resistant GC cells, overexpression of HMGA1P4 upregulated MDR-related genes and downregulated apoptosis-related genes.
CONCLUSIONS: HMGA1P4 is upregulated in DDP-resistant GC tissues and cells, and triggers the progression of DDP-resistance in GC.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32964971     DOI: 10.26355/eurrev_202009_22822

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  9 in total

1.  Identification of new proteins related with cisplatin resistance in Saccharomyces cerevisiae.

Authors:  Antonio M Burgos-Molina; Silvia Mercado-Sáenz; Casimiro Cárdenas; Beatriz López-Díaz; Francisco Sendra-Portero; Miguel J Ruiz-Gómez
Journal:  Appl Microbiol Biotechnol       Date:  2021-02-12       Impact factor: 4.813

2.  The Long Non-coding RNA AC148477.2 Is a Novel Therapeutic Target Associated With Vascular Smooth Muscle Cells Proliferation of Femoral Atherosclerosis.

Authors:  Kangjie Wang; Yanchen Ye; Lin Huang; Ridong Wu; Rongzhou He; Chen Yao; Shenming Wang
Journal:  Front Cardiovasc Med       Date:  2022-07-06

Review 3.  The Molecular Roles and Clinical Implications of Non-Coding RNAs in Gastric Cancer.

Authors:  Yanping Yue; Xinrong Lin; Xinyue Qiu; Lei Yang; Rui Wang
Journal:  Front Cell Dev Biol       Date:  2021-12-13

4.  LncRNA FOXP4-AS1 Promotes the Progression of Esophageal Squamous Cell Carcinoma by Interacting With MLL2/H3K4me3 to Upregulate FOXP4.

Authors:  Yunfeng Niu; Gaoyan Wang; Yan Li; Wei Guo; Yanli Guo; Zhiming Dong
Journal:  Front Oncol       Date:  2021-12-14       Impact factor: 6.244

Review 5.  Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance.

Authors:  Ying Liu; Xiang Ao; Yu Wang; Xiaoge Li; Jianxun Wang
Journal:  Front Oncol       Date:  2022-01-28       Impact factor: 6.244

6.  Comprehensive Analysis and Prognosis Prediction of N6-Methyladenosine-Related lncRNAs in Immune Microenvironment Infiltration of Gastric Cancer.

Authors:  Jianfeng Huang; Wenzheng Chen; Changyu Chen; Zhigang Jie; Tao Xiao
Journal:  Int J Gen Med       Date:  2022-03-08

7.  Knockdown of lncRNA ACTA2-AS1 reverses cisplatin resistance of ovarian cancer cells via inhibition of miR-378a-3p-regulated Wnt5a.

Authors:  Chenxiao Lin; Meiyun Zheng; Youlin Yang; Yi Chen; Xiahui Zhang; Lingping Zhu; Haiyan Zhang
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

8.  A novel marker based on necroptosis-related long non-coding RNA for forecasting prognostic in patients with clear cell renal cell carcinoma.

Authors:  Jinxing Lv; Qinghui Xu; Guoqing Wu; Jian Hou; Guang Yang; Cheng Tang; Genyi Qu; Yong Xu
Journal:  Front Genet       Date:  2022-09-21       Impact factor: 4.772

9.  Long non-coding RNA LINC00649 regulates YES-associated protein 1 (YAP1)/Hippo pathway to accelerate gastric cancer (GC) progression via sequestering miR-16-5p.

Authors:  Hongyan Wang; Xin Di; Yingjie Bi; Shidong Sun; Tao Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.